Norwegian doctors are increasingly prescribing an unapproved medication to patients seeking treatment for sleep disorders. The drug’s use is occurring despite its lack of official authorization, prompting concern among health officials. While the specific medication isn’t named in reports, the practice highlights a gap in available, approved treatments for insomnia and other sleep-related issues. Authorities have issued warnings regarding the problematic nature of prescribing a drug that hasn’t undergone the standard regulatory review process. The reasons for the widespread prescription appear to stem from patient demand and limited alternatives. Further investigation is expected to determine the extent of the practice and potential risks to patients. The situation underscores the need for increased access to approved sleep therapies.